2022
Impact Factor
7.4
2016, Vol. 7(2): 201-214    DOI: 10.14336/AD.2015.1007
Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
Isaac G. Onyango1,*, Jameel Dennis1, Shaharyah M. Khan1
1. Gencia Biotechnology, 706 B Forest St, Charlottesville, VA 22903, USA
Received 2015-09-02  Revised null
Supporting info